Equity Under Siege: NIH Funding Cuts Target Marginalized Voices

Recent revocations of federal grants designated for research into health equity and gender identity have demonstrably impacted scientists from the very demographics these studies are intended to benefit, according to an investigation by the University of California, San Diego Herbert Wertheim School of Public Health and Human Longevity Science. The comprehensive findings were disseminated on May 5, 2026, within the esteemed pages of The Lancet Regional Health – Americas.

The cessation of these grant awards not only impeded specific research endeavors but also significantly disrupted the professional trajectories of numerous investigators deeply engaged in the study of marginalized communities’ health. When funding streams for these critical areas diminish, it is frequently the researchers possessing the most profound expertise who bear the brunt of the repercussions.”

Rebecca Fielding-Miller, PhD, associate professor at the UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science and senior author of the study

As the preeminent global public financier of biomedical investigations, the National Institutes of Health (NIH) allocates approximately $47 billion each year. Given the magnitude of this financial commitment, the research directives established within the United States profoundly influence the global trajectory of health science advancements.

Between the months of January and May of 2025, the NIH rescinded over 2,000 research grants following a strategic realignment of the agency’s priorities. A substantial number of these affected grants were dedicated to exploring health disparities, encompassing research pertinent to Black, Indigenous, and People of Color (BIPOC) communities, as well as sexual and gender minorities. Furthermore, approximately 600 grants were unilaterally canceled as part of institution-wide measures intended to counter alleged instances of antisemitism on campuses.

To ascertain the extent of the impact and identify the most affected individuals, the research cadre conducted a survey of investigators whose terminated grants were cataloged in the Grant Witness repository. Out of 1,918 investigators invited to participate, 941 successfully completed the questionnaire. To facilitate the classification of terminations by their stated rationale, participants were prompted to select from eight potential justifications for the grant’s cessation. For instance, investigators were categorized as having experienced an equity-related termination if they indicated the grant was withdrawn due to “vague equity objectives,” and a gender-related termination if the reason cited was “gender identity.”

The ensuing analysis revealed that nearly half (48.6%) of the investigators whose grants were terminated for equity-related justifications self-identified as BIPOC. Within the cohort of grants terminated for gender-related reasons, a significant 60% of the investigators identified as belonging to sexual or gender minority groups, with 16.5% of this subgroup identifying as transgender or nonbinary. These disparities transcended mere statistical representation. Among the investigators whose grants faced termination, BIPOC women and transgender or nonbinary researchers exhibited nearly triple the likelihood of experiencing an equity-related grant cessation compared to their White male counterparts. Similarly, sexual and gender minority investigators were over eleven times more prone to receive a gender-related termination than their heterosexual, cisgender peers.

The investigation further brought to light that 20.5% of investigators impacted by institution-wide terminations linked to purported antisemitism identified as Jewish, thereby raising critical questions regarding the efficacy of such broad actions as a protective measure for Jewish researchers.

These revelations build upon prior scholarly work that has consistently identified pre-existing inequities within the biomedical funding ecosystem. Previous studies have underscored a recurrent pattern wherein scientists hailing from underrepresented backgrounds are more inclined to focus their research on health disparities or community-centric issues, areas that have historically attracted less substantial financial backing.

“When funding interruptions disproportionately disadvantage researchers concentrating on health disparities, the ramifications extend far beyond the confines of individual careers,” stated Fielding-Miller. “These disruptions also exert a significant influence on the types of scientific inquiries that are pursued and, consequently, which populations’ health issues ultimately garner critical attention.”

The authors issue a cautionary note, suggesting that the repercussions of these funding shifts could resonate for an extended period. Given that research careers and the attainment of funding success tend to accumulate incrementally over time, the loss of even a single grant can precipitate the derailment of projects, compromise established community partnerships, and curtail future funding prospects, particularly for researchers in the nascent stages of their careers.

Looking toward the future, the researchers emphasize that the reinstatement and sustained provision of financial support for equity-focused health research are paramount. Such measures are deemed essential for cultivating a diverse scientific workforce and ensuring that the landscape of biomedical research adequately reflects and addresses the multifaceted needs of all communities.

“If our ambition is to foster a scientific enterprise that genuinely serves every individual,” Fielding-Miller asserted, “it is imperative that we guarantee the continued capacity of scientists who are dedicated to investigating the health challenges faced by marginalized communities to pursue their vital work.”